University of Regensburg
uni-regensburg.deTotal trials
69
Active
7
Phase 3
5
Total enrollment
7,187
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Depression9
- Chronic Tinnitus9
- Tinnitus6
- Peritoneal Carcinomatosis2
- Colorectal Cancer Metastatic2
- Postoperative Residual Curarization2
- Hepatocellular Carcinoma2
- Schizophrenia2
Frequently asked questions about University of Regensburg
- How many clinical trials does University of Regensburg have on ClinicalTrials.gov?
- University of Regensburg is listed as the lead sponsor on 69 clinical trials in ClinicalTrials.gov, 7 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Regensburg's trials are in Phase 3?
- 5 of University of Regensburg's trials are in Phase 3.
- What therapeutic areas does University of Regensburg focus on?
- University of Regensburg's most-studied conditions on ClinicalTrials.gov are Depression, Chronic Tinnitus, Tinnitus, Peritoneal Carcinomatosis, Colorectal Cancer Metastatic.